nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.055	0.0879	CbGbCtD
Exemestane—CYP3A4—Felbamate—epilepsy syndrome	0.0511	0.0817	CbGbCtD
Exemestane—CYP3A4—Trimethadione—epilepsy syndrome	0.0511	0.0817	CbGbCtD
Exemestane—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0481	0.0768	CbGbCtD
Exemestane—CYP3A4—Clonazepam—epilepsy syndrome	0.0435	0.0695	CbGbCtD
Exemestane—CYP3A4—Clobazam—epilepsy syndrome	0.0417	0.0666	CbGbCtD
Exemestane—CYP3A4—Rufinamide—epilepsy syndrome	0.0355	0.0566	CbGbCtD
Exemestane—CYP3A4—Carbamazepine—epilepsy syndrome	0.0346	0.0552	CbGbCtD
Exemestane—CYP3A4—Primidone—epilepsy syndrome	0.0323	0.0515	CbGbCtD
Exemestane—CYP3A4—Phenytoin—epilepsy syndrome	0.031	0.0495	CbGbCtD
Exemestane—CYP3A4—Propofol—epilepsy syndrome	0.0289	0.0462	CbGbCtD
Exemestane—CYP3A4—Phenobarbital—epilepsy syndrome	0.0276	0.0441	CbGbCtD
Exemestane—CYP3A4—Acetazolamide—epilepsy syndrome	0.0276	0.0441	CbGbCtD
Exemestane—CYP3A4—Midazolam—epilepsy syndrome	0.0272	0.0435	CbGbCtD
Exemestane—CYP3A4—Diazepam—epilepsy syndrome	0.0262	0.0418	CbGbCtD
Exemestane—CYP3A4—Zonisamide—epilepsy syndrome	0.0256	0.0408	CbGbCtD
Exemestane—CYP3A4—Valproic Acid—epilepsy syndrome	0.0206	0.033	CbGbCtD
Exemestane—CYP3A4—Topiramate—epilepsy syndrome	0.0186	0.0297	CbGbCtD
Exemestane—Prednisone—SLCO1A2—epilepsy syndrome	0.000678	0.0972	CrCbGaD
Exemestane—Prednisolone—SLCO1A2—epilepsy syndrome	0.000625	0.0896	CrCbGaD
Exemestane—Conjugated Estrogens—SLCO1A2—epilepsy syndrome	0.000607	0.087	CrCbGaD
Exemestane—Estrone—SLCO1A2—epilepsy syndrome	0.000605	0.0868	CrCbGaD
Exemestane—CYP19A1—Tryptophan metabolism—WARS—epilepsy syndrome	0.000532	0.0566	CbGpPWpGaD
Exemestane—Loteprednol—NR3C1—epilepsy syndrome	0.000519	0.0744	CrCbGaD
Exemestane—Testosterone—SLCO1A2—epilepsy syndrome	0.000368	0.0528	CrCbGaD
Exemestane—Methylprednisolone—NR3C1—epilepsy syndrome	0.000323	0.0463	CrCbGaD
Exemestane—Testosterone—CYP11A1—epilepsy syndrome	0.00032	0.0459	CrCbGaD
Exemestane—CYP19A1—Endogenous sterols—CYP11A1—epilepsy syndrome	0.000304	0.0323	CbGpPWpGaD
Exemestane—Conjugated Estrogens—ABCC2—epilepsy syndrome	0.00029	0.0416	CrCbGaD
Exemestane—Conjugated Estrogens—ABCG2—epilepsy syndrome	0.000256	0.0368	CrCbGaD
Exemestane—Estrone—ABCG2—epilepsy syndrome	0.000256	0.0367	CrCbGaD
Exemestane—CYP3A4—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	0.000251	0.0267	CbGpPWpGaD
Exemestane—CYP19A1—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.000248	0.0264	CbGpPWpGaD
Exemestane—Prednisone—NR3C1—epilepsy syndrome	0.000247	0.0354	CrCbGaD
Exemestane—Prednisolone—NR3C1—epilepsy syndrome	0.000228	0.0327	CrCbGaD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—epilepsy syndrome	0.000228	0.0242	CbGpPWpGaD
Exemestane—Prednisone—CYP2C19—epilepsy syndrome	0.000225	0.0323	CrCbGaD
Exemestane—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.000186	0.0198	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000183	0.0195	CbGpPWpGaD
Exemestane—Estropipate—ALB—epilepsy syndrome	0.000179	0.0257	CrCbGaD
Exemestane—CYP19A1—FSH signaling pathway—BDNF—epilepsy syndrome	0.000175	0.0186	CbGpPWpGaD
Exemestane—CYP3A4—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.00016	0.017	CbGpPWpGaD
Exemestane—Methylprednisolone—ABCB1—epilepsy syndrome	0.000156	0.0224	CrCbGaD
Exemestane—Testosterone—ABCG2—epilepsy syndrome	0.000156	0.0223	CrCbGaD
Exemestane—CYP3A4—Tryptophan metabolism—WARS—epilepsy syndrome	0.000155	0.0165	CbGpPWpGaD
Exemestane—CYP19A1—Ovarian Infertility Genes—VDR—epilepsy syndrome	0.00015	0.016	CbGpPWpGaD
Exemestane—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000146	0.000409	CcSEcCtD
Exemestane—Dizziness—Diazepam—epilepsy syndrome	0.000146	0.000409	CcSEcCtD
Exemestane—Infection—Valproic Acid—epilepsy syndrome	0.000146	0.000408	CcSEcCtD
Exemestane—Leukopenia—Pregabalin—epilepsy syndrome	0.000146	0.000407	CcSEcCtD
Exemestane—Rash—Fosphenytoin—epilepsy syndrome	0.000145	0.000406	CcSEcCtD
Exemestane—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000145	0.000406	CcSEcCtD
Exemestane—Haemoglobin—Topiramate—epilepsy syndrome	0.000145	0.000405	CcSEcCtD
Exemestane—Asthenia—Clonazepam—epilepsy syndrome	0.000145	0.000405	CcSEcCtD
Exemestane—Rhinitis—Topiramate—epilepsy syndrome	0.000145	0.000404	CcSEcCtD
Exemestane—Back pain—Gabapentin—epilepsy syndrome	0.000144	0.000404	CcSEcCtD
Exemestane—Headache—Fosphenytoin—epilepsy syndrome	0.000144	0.000403	CcSEcCtD
Exemestane—Haemorrhage—Topiramate—epilepsy syndrome	0.000144	0.000403	CcSEcCtD
Exemestane—Hepatitis—Topiramate—epilepsy syndrome	0.000144	0.000403	CcSEcCtD
Exemestane—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000144	0.000403	CcSEcCtD
Exemestane—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000144	0.000402	CcSEcCtD
Exemestane—Asthenia—Phenytoin—epilepsy syndrome	0.000144	0.000402	CcSEcCtD
Exemestane—Nausea—Midazolam—epilepsy syndrome	0.000143	0.000401	CcSEcCtD
Exemestane—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000143	0.000401	CcSEcCtD
Exemestane—Muscle spasms—Gabapentin—epilepsy syndrome	0.000143	0.000401	CcSEcCtD
Exemestane—Diarrhoea—Zonisamide—epilepsy syndrome	0.000143	0.000401	CcSEcCtD
Exemestane—Pharyngitis—Topiramate—epilepsy syndrome	0.000143	0.0004	CcSEcCtD
Exemestane—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000143	0.0004	CcSEcCtD
Exemestane—Pruritus—Clonazepam—epilepsy syndrome	0.000143	0.000399	CcSEcCtD
Exemestane—Vomiting—Vigabatrin—epilepsy syndrome	0.000143	0.000399	CcSEcCtD
Exemestane—Skin disorder—Valproic Acid—epilepsy syndrome	0.000143	0.000399	CcSEcCtD
Exemestane—Oedema peripheral—Topiramate—epilepsy syndrome	0.000142	0.000397	CcSEcCtD
Exemestane—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000142	0.000397	CcSEcCtD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000142	0.0151	CbGpPWpGaD
Exemestane—Cough—Pregabalin—epilepsy syndrome	0.000142	0.000397	CcSEcCtD
Exemestane—Pruritus—Phenytoin—epilepsy syndrome	0.000142	0.000397	CcSEcCtD
Exemestane—Nausea—Levetiracetam—epilepsy syndrome	0.000142	0.000396	CcSEcCtD
Exemestane—Rash—Vigabatrin—epilepsy syndrome	0.000141	0.000396	CcSEcCtD
Exemestane—Dizziness—Felbamate—epilepsy syndrome	0.000141	0.000396	CcSEcCtD
Exemestane—Dermatitis—Vigabatrin—epilepsy syndrome	0.000141	0.000395	CcSEcCtD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.000141	0.015	CbGpPWpGaD
Exemestane—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000141	0.000394	CcSEcCtD
Exemestane—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000141	0.000394	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—TSC2—epilepsy syndrome	0.000141	0.015	CbGpPWpGaD
Exemestane—Headache—Vigabatrin—epilepsy syndrome	0.000141	0.000393	CcSEcCtD
Exemestane—Hypertension—Pregabalin—epilepsy syndrome	0.00014	0.000393	CcSEcCtD
Exemestane—Vomiting—Diazepam—epilepsy syndrome	0.00014	0.000393	CcSEcCtD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.00014	0.0149	CbGpPWpGaD
Exemestane—Anorexia—Valproic Acid—epilepsy syndrome	0.00014	0.000392	CcSEcCtD
Exemestane—Rash—Diazepam—epilepsy syndrome	0.000139	0.00039	CcSEcCtD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.000139	0.0148	CbGpPWpGaD
Exemestane—Dermatitis—Diazepam—epilepsy syndrome	0.000139	0.000389	CcSEcCtD
Exemestane—Visual impairment—Topiramate—epilepsy syndrome	0.000139	0.000389	CcSEcCtD
Exemestane—Myalgia—Pregabalin—epilepsy syndrome	0.000139	0.000388	CcSEcCtD
Exemestane—Arthralgia—Pregabalin—epilepsy syndrome	0.000139	0.000388	CcSEcCtD
Exemestane—Chest pain—Pregabalin—epilepsy syndrome	0.000139	0.000388	CcSEcCtD
Exemestane—Dizziness—Zonisamide—epilepsy syndrome	0.000138	0.000387	CcSEcCtD
Exemestane—Headache—Diazepam—epilepsy syndrome	0.000138	0.000387	CcSEcCtD
Exemestane—Anxiety—Pregabalin—epilepsy syndrome	0.000138	0.000386	CcSEcCtD
Exemestane—Diarrhoea—Clonazepam—epilepsy syndrome	0.000138	0.000386	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000138	0.000385	CcSEcCtD
Exemestane—Asthenia—Carbamazepine—epilepsy syndrome	0.000137	0.000384	CcSEcCtD
Exemestane—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	0.000137	0.0146	CbGpPWpGaD
Exemestane—Diarrhoea—Phenytoin—epilepsy syndrome	0.000137	0.000384	CcSEcCtD
Exemestane—Nausea—Fosphenytoin—epilepsy syndrome	0.000137	0.000383	CcSEcCtD
Exemestane—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000136	0.000381	CcSEcCtD
Exemestane—Erythema multiforme—Topiramate—epilepsy syndrome	0.000136	0.000381	CcSEcCtD
Exemestane—CYP3A4—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.000136	0.0145	CbGpPWpGaD
Exemestane—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000136	0.000381	CcSEcCtD
Exemestane—Vomiting—Felbamate—epilepsy syndrome	0.000136	0.00038	CcSEcCtD
Exemestane—Pruritus—Carbamazepine—epilepsy syndrome	0.000135	0.000379	CcSEcCtD
Exemestane—Rash—Felbamate—epilepsy syndrome	0.000135	0.000377	CcSEcCtD
Exemestane—Dermatitis—Felbamate—epilepsy syndrome	0.000135	0.000377	CcSEcCtD
Exemestane—Malaise—Gabapentin—epilepsy syndrome	0.000135	0.000376	CcSEcCtD
Exemestane—CYP19A1—Endogenous sterols—POMC—epilepsy syndrome	0.000134	0.0143	CbGpPWpGaD
Exemestane—Headache—Felbamate—epilepsy syndrome	0.000134	0.000375	CcSEcCtD
Exemestane—Confusional state—Pregabalin—epilepsy syndrome	0.000134	0.000375	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000134	0.000374	CcSEcCtD
Exemestane—Cardiac disorder—Topiramate—epilepsy syndrome	0.000134	0.000374	CcSEcCtD
Exemestane—Leukopenia—Gabapentin—epilepsy syndrome	0.000134	0.000374	CcSEcCtD
Exemestane—Dizziness—Clonazepam—epilepsy syndrome	0.000133	0.000373	CcSEcCtD
Exemestane—Nausea—Vigabatrin—epilepsy syndrome	0.000133	0.000373	CcSEcCtD
Exemestane—Vomiting—Zonisamide—epilepsy syndrome	0.000133	0.000372	CcSEcCtD
Exemestane—CYP3A4—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	0.000133	0.0142	CbGpPWpGaD
Exemestane—Insomnia—Valproic Acid—epilepsy syndrome	0.000133	0.000372	CcSEcCtD
Exemestane—Oedema—Pregabalin—epilepsy syndrome	0.000133	0.000371	CcSEcCtD
Exemestane—Asthenia—Lamotrigine—epilepsy syndrome	0.000133	0.000371	CcSEcCtD
Exemestane—Dizziness—Phenytoin—epilepsy syndrome	0.000132	0.000371	CcSEcCtD
Exemestane—Rash—Zonisamide—epilepsy syndrome	0.000132	0.000369	CcSEcCtD
Exemestane—Infection—Pregabalin—epilepsy syndrome	0.000132	0.000369	CcSEcCtD
Exemestane—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000132	0.000369	CcSEcCtD
Exemestane—Dermatitis—Zonisamide—epilepsy syndrome	0.000132	0.000369	CcSEcCtD
Exemestane—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000132	0.000369	CcSEcCtD
Exemestane—Nausea—Diazepam—epilepsy syndrome	0.000131	0.000367	CcSEcCtD
Exemestane—Headache—Zonisamide—epilepsy syndrome	0.000131	0.000367	CcSEcCtD
Exemestane—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000131	0.000366	CcSEcCtD
Exemestane—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000131	0.000366	CcSEcCtD
Exemestane—Pruritus—Lamotrigine—epilepsy syndrome	0.000131	0.000366	CcSEcCtD
Exemestane—Immune system disorder—Topiramate—epilepsy syndrome	0.00013	0.000364	CcSEcCtD
Exemestane—Nervous system disorder—Pregabalin—epilepsy syndrome	0.00013	0.000364	CcSEcCtD
Exemestane—Cough—Gabapentin—epilepsy syndrome	0.00013	0.000364	CcSEcCtD
Exemestane—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.00013	0.000364	CcSEcCtD
Exemestane—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000129	0.000362	CcSEcCtD
Exemestane—Skin disorder—Pregabalin—epilepsy syndrome	0.000129	0.000361	CcSEcCtD
Exemestane—Hypertension—Gabapentin—epilepsy syndrome	0.000129	0.00036	CcSEcCtD
Exemestane—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000128	0.000359	CcSEcCtD
Exemestane—Vomiting—Clonazepam—epilepsy syndrome	0.000128	0.000359	CcSEcCtD
Exemestane—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000128	0.000357	CcSEcCtD
Exemestane—Alopecia—Topiramate—epilepsy syndrome	0.000127	0.000356	CcSEcCtD
Exemestane—Vomiting—Phenytoin—epilepsy syndrome	0.000127	0.000356	CcSEcCtD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	0.000127	0.0136	CbGpPWpGaD
Exemestane—Rash—Clonazepam—epilepsy syndrome	0.000127	0.000356	CcSEcCtD
Exemestane—Dermatitis—Clonazepam—epilepsy syndrome	0.000127	0.000355	CcSEcCtD
Exemestane—Myalgia—Gabapentin—epilepsy syndrome	0.000127	0.000355	CcSEcCtD
Exemestane—Arthralgia—Gabapentin—epilepsy syndrome	0.000127	0.000355	CcSEcCtD
Exemestane—Chest pain—Gabapentin—epilepsy syndrome	0.000127	0.000355	CcSEcCtD
Exemestane—Nausea—Felbamate—epilepsy syndrome	0.000127	0.000355	CcSEcCtD
Exemestane—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000127	0.000355	CcSEcCtD
Exemestane—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000127	0.000355	CcSEcCtD
Exemestane—Fatigue—Valproic Acid—epilepsy syndrome	0.000127	0.000354	CcSEcCtD
Exemestane—Anxiety—Gabapentin—epilepsy syndrome	0.000127	0.000354	CcSEcCtD
Exemestane—Anorexia—Pregabalin—epilepsy syndrome	0.000127	0.000354	CcSEcCtD
Exemestane—Dizziness—Carbamazepine—epilepsy syndrome	0.000126	0.000354	CcSEcCtD
Exemestane—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000126	0.000354	CcSEcCtD
Exemestane—Headache—Clonazepam—epilepsy syndrome	0.000126	0.000354	CcSEcCtD
Exemestane—Rash—Phenytoin—epilepsy syndrome	0.000126	0.000353	CcSEcCtD
Exemestane—Mental disorder—Topiramate—epilepsy syndrome	0.000126	0.000353	CcSEcCtD
Exemestane—Dermatitis—Phenytoin—epilepsy syndrome	0.000126	0.000353	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000126	0.000353	CcSEcCtD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.000126	0.0134	CbGpPWpGaD
Exemestane—Rash—Oxcarbazepine—epilepsy syndrome	0.000126	0.000352	CcSEcCtD
Exemestane—Pain—Valproic Acid—epilepsy syndrome	0.000126	0.000351	CcSEcCtD
Exemestane—Constipation—Valproic Acid—epilepsy syndrome	0.000126	0.000351	CcSEcCtD
Exemestane—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000126	0.000351	CcSEcCtD
Exemestane—Headache—Phenytoin—epilepsy syndrome	0.000126	0.000351	CcSEcCtD
Exemestane—Prednisone—ALB—epilepsy syndrome	0.000125	0.0179	CrCbGaD
Exemestane—Headache—Oxcarbazepine—epilepsy syndrome	0.000125	0.000349	CcSEcCtD
Exemestane—Nausea—Zonisamide—epilepsy syndrome	0.000124	0.000348	CcSEcCtD
Exemestane—Confusional state—Gabapentin—epilepsy syndrome	0.000123	0.000343	CcSEcCtD
Exemestane—Testosterone—CYP2C19—epilepsy syndrome	0.000122	0.0175	CrCbGaD
Exemestane—Dizziness—Lamotrigine—epilepsy syndrome	0.000122	0.000342	CcSEcCtD
Exemestane—Oedema—Gabapentin—epilepsy syndrome	0.000122	0.000341	CcSEcCtD
Exemestane—Vomiting—Carbamazepine—epilepsy syndrome	0.000122	0.00034	CcSEcCtD
Exemestane—Back pain—Topiramate—epilepsy syndrome	0.000121	0.00034	CcSEcCtD
Exemestane—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000121	0.000339	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000121	0.000338	CcSEcCtD
Exemestane—Infection—Gabapentin—epilepsy syndrome	0.000121	0.000338	CcSEcCtD
Exemestane—Muscle spasms—Topiramate—epilepsy syndrome	0.000121	0.000338	CcSEcCtD
Exemestane—Rash—Carbamazepine—epilepsy syndrome	0.000121	0.000337	CcSEcCtD
Exemestane—Dermatitis—Carbamazepine—epilepsy syndrome	0.00012	0.000337	CcSEcCtD
Exemestane—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.00012	0.000336	CcSEcCtD
Exemestane—Insomnia—Pregabalin—epilepsy syndrome	0.00012	0.000336	CcSEcCtD
Exemestane—Nausea—Clonazepam—epilepsy syndrome	0.00012	0.000335	CcSEcCtD
Exemestane—Headache—Carbamazepine—epilepsy syndrome	0.00012	0.000335	CcSEcCtD
Exemestane—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000119	0.000334	CcSEcCtD
Exemestane—Paraesthesia—Pregabalin—epilepsy syndrome	0.000119	0.000334	CcSEcCtD
Exemestane—Prednisone—ABCB1—epilepsy syndrome	0.000119	0.0171	CrCbGaD
Exemestane—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000119	0.000334	CcSEcCtD
Exemestane—Nausea—Phenytoin—epilepsy syndrome	0.000119	0.000333	CcSEcCtD
Exemestane—Dyspnoea—Pregabalin—epilepsy syndrome	0.000118	0.000331	CcSEcCtD
Exemestane—Nausea—Oxcarbazepine—epilepsy syndrome	0.000118	0.000331	CcSEcCtD
Exemestane—Skin disorder—Gabapentin—epilepsy syndrome	0.000118	0.000331	CcSEcCtD
Exemestane—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000118	0.000329	CcSEcCtD
Exemestane—Vomiting—Lamotrigine—epilepsy syndrome	0.000118	0.000329	CcSEcCtD
Exemestane—Urticaria—Valproic Acid—epilepsy syndrome	0.000117	0.000326	CcSEcCtD
Exemestane—Rash—Lamotrigine—epilepsy syndrome	0.000117	0.000326	CcSEcCtD
Exemestane—Dermatitis—Lamotrigine—epilepsy syndrome	0.000116	0.000326	CcSEcCtD
Exemestane—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000116	0.000325	CcSEcCtD
Exemestane—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000116	0.000325	CcSEcCtD
Exemestane—Anorexia—Gabapentin—epilepsy syndrome	0.000116	0.000325	CcSEcCtD
Exemestane—Headache—Lamotrigine—epilepsy syndrome	0.000116	0.000324	CcSEcCtD
Exemestane—CYP19A1—Ovarian Infertility Genes—ATM—epilepsy syndrome	0.000116	0.0123	CbGpPWpGaD
Exemestane—CYP19A1—Tryptophan metabolism—CAT—epilepsy syndrome	0.000116	0.0123	CbGpPWpGaD
Exemestane—Decreased appetite—Pregabalin—epilepsy syndrome	0.000115	0.000323	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.000115	0.0122	CbGpPWpGaD
Exemestane—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000115	0.000321	CcSEcCtD
Exemestane—Fatigue—Pregabalin—epilepsy syndrome	0.000114	0.00032	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.000114	0.0122	CbGpPWpGaD
Exemestane—Nausea—Carbamazepine—epilepsy syndrome	0.000114	0.000318	CcSEcCtD
Exemestane—Constipation—Pregabalin—epilepsy syndrome	0.000114	0.000318	CcSEcCtD
Exemestane—Pain—Pregabalin—epilepsy syndrome	0.000114	0.000318	CcSEcCtD
Exemestane—Malaise—Topiramate—epilepsy syndrome	0.000113	0.000317	CcSEcCtD
Exemestane—CYP3A4—Irinotecan Pathway—BCHE—epilepsy syndrome	0.000113	0.012	CbGpPWpGaD
Exemestane—Leukopenia—Topiramate—epilepsy syndrome	0.000112	0.000314	CcSEcCtD
Exemestane—Estrone—ALB—epilepsy syndrome	0.000112	0.016	CrCbGaD
Exemestane—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000111	0.00031	CcSEcCtD
Exemestane—Insomnia—Gabapentin—epilepsy syndrome	0.00011	0.000308	CcSEcCtD
Exemestane—Prednisolone—ABCB1—epilepsy syndrome	0.00011	0.0158	CrCbGaD
Exemestane—Nausea—Lamotrigine—epilepsy syndrome	0.00011	0.000307	CcSEcCtD
Exemestane—Cough—Topiramate—epilepsy syndrome	0.00011	0.000306	CcSEcCtD
Exemestane—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000109	0.000306	CcSEcCtD
Exemestane—Paraesthesia—Gabapentin—epilepsy syndrome	0.000109	0.000306	CcSEcCtD
Exemestane—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000109	0.000304	CcSEcCtD
Exemestane—Dyspnoea—Gabapentin—epilepsy syndrome	0.000109	0.000304	CcSEcCtD
Exemestane—Hypertension—Topiramate—epilepsy syndrome	0.000108	0.000303	CcSEcCtD
Exemestane—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000108	0.000303	CcSEcCtD
Exemestane—Dyspepsia—Gabapentin—epilepsy syndrome	0.000107	0.0003	CcSEcCtD
Exemestane—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	0.000107	0.0114	CbGpPWpGaD
Exemestane—Myalgia—Topiramate—epilepsy syndrome	0.000107	0.000299	CcSEcCtD
Exemestane—Arthralgia—Topiramate—epilepsy syndrome	0.000107	0.000299	CcSEcCtD
Exemestane—Chest pain—Topiramate—epilepsy syndrome	0.000107	0.000299	CcSEcCtD
Exemestane—Conjugated Estrogens—ABCB1—epilepsy syndrome	0.000107	0.0153	CrCbGaD
Exemestane—Anxiety—Topiramate—epilepsy syndrome	0.000106	0.000298	CcSEcCtD
Exemestane—Estrone—ABCB1—epilepsy syndrome	0.000106	0.0153	CrCbGaD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000106	0.000297	CcSEcCtD
Exemestane—Decreased appetite—Gabapentin—epilepsy syndrome	0.000106	0.000296	CcSEcCtD
Exemestane—Urticaria—Pregabalin—epilepsy syndrome	0.000105	0.000295	CcSEcCtD
Exemestane—Asthenia—Valproic Acid—epilepsy syndrome	0.000105	0.000295	CcSEcCtD
Exemestane—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000105	0.000294	CcSEcCtD
Exemestane—Fatigue—Gabapentin—epilepsy syndrome	0.000105	0.000294	CcSEcCtD
Exemestane—Abdominal pain—Pregabalin—epilepsy syndrome	0.000105	0.000294	CcSEcCtD
Exemestane—Body temperature increased—Pregabalin—epilepsy syndrome	0.000105	0.000294	CcSEcCtD
Exemestane—Pain—Gabapentin—epilepsy syndrome	0.000104	0.000291	CcSEcCtD
Exemestane—Constipation—Gabapentin—epilepsy syndrome	0.000104	0.000291	CcSEcCtD
Exemestane—Pruritus—Valproic Acid—epilepsy syndrome	0.000104	0.000291	CcSEcCtD
Exemestane—Confusional state—Topiramate—epilepsy syndrome	0.000103	0.000289	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	0.000103	0.011	CbGpPWpGaD
Exemestane—Oedema—Topiramate—epilepsy syndrome	0.000102	0.000287	CcSEcCtD
Exemestane—Infection—Topiramate—epilepsy syndrome	0.000102	0.000285	CcSEcCtD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—epilepsy syndrome	0.000101	0.0107	CbGpPWpGaD
Exemestane—Diarrhoea—Valproic Acid—epilepsy syndrome	0.0001	0.000281	CcSEcCtD
Exemestane—Nervous system disorder—Topiramate—epilepsy syndrome	0.0001	0.000281	CcSEcCtD
Exemestane—Feeling abnormal—Gabapentin—epilepsy syndrome	0.0001	0.000281	CcSEcCtD
Exemestane—Thrombocytopenia—Topiramate—epilepsy syndrome	0.0001	0.000281	CcSEcCtD
Exemestane—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	9.98e-05	0.0106	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Gabapentin—epilepsy syndrome	9.96e-05	0.000279	CcSEcCtD
Exemestane—Skin disorder—Topiramate—epilepsy syndrome	9.95e-05	0.000278	CcSEcCtD
Exemestane—Hyperhidrosis—Topiramate—epilepsy syndrome	9.9e-05	0.000277	CcSEcCtD
Exemestane—Hypersensitivity—Pregabalin—epilepsy syndrome	9.78e-05	0.000274	CcSEcCtD
Exemestane—Anorexia—Topiramate—epilepsy syndrome	9.76e-05	0.000273	CcSEcCtD
Exemestane—Dizziness—Valproic Acid—epilepsy syndrome	9.71e-05	0.000272	CcSEcCtD
Exemestane—Urticaria—Gabapentin—epilepsy syndrome	9.67e-05	0.000271	CcSEcCtD
Exemestane—Abdominal pain—Gabapentin—epilepsy syndrome	9.63e-05	0.000269	CcSEcCtD
Exemestane—Body temperature increased—Gabapentin—epilepsy syndrome	9.63e-05	0.000269	CcSEcCtD
Exemestane—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	9.6e-05	0.0102	CbGpPWpGaD
Exemestane—Asthenia—Pregabalin—epilepsy syndrome	9.53e-05	0.000267	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—MTOR—epilepsy syndrome	9.51e-05	0.0101	CbGpPWpGaD
Exemestane—Pruritus—Pregabalin—epilepsy syndrome	9.39e-05	0.000263	CcSEcCtD
Exemestane—Vomiting—Valproic Acid—epilepsy syndrome	9.34e-05	0.000261	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	9.33e-05	0.000261	CcSEcCtD
Exemestane—Insomnia—Topiramate—epilepsy syndrome	9.26e-05	0.000259	CcSEcCtD
Exemestane—Rash—Valproic Acid—epilepsy syndrome	9.26e-05	0.000259	CcSEcCtD
Exemestane—Dermatitis—Valproic Acid—epilepsy syndrome	9.25e-05	0.000259	CcSEcCtD
Exemestane—Headache—Valproic Acid—epilepsy syndrome	9.2e-05	0.000257	CcSEcCtD
Exemestane—Paraesthesia—Topiramate—epilepsy syndrome	9.2e-05	0.000257	CcSEcCtD
Exemestane—Dyspnoea—Topiramate—epilepsy syndrome	9.13e-05	0.000256	CcSEcCtD
Exemestane—Diarrhoea—Pregabalin—epilepsy syndrome	9.08e-05	0.000254	CcSEcCtD
Exemestane—Dyspepsia—Topiramate—epilepsy syndrome	9.02e-05	0.000252	CcSEcCtD
Exemestane—Hypersensitivity—Gabapentin—epilepsy syndrome	8.97e-05	0.000251	CcSEcCtD
Exemestane—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	8.95e-05	0.00952	CbGpPWpGaD
Exemestane—Decreased appetite—Topiramate—epilepsy syndrome	8.9e-05	0.000249	CcSEcCtD
Exemestane—Gastrointestinal disorder—Topiramate—epilepsy syndrome	8.84e-05	0.000247	CcSEcCtD
Exemestane—Fatigue—Topiramate—epilepsy syndrome	8.83e-05	0.000247	CcSEcCtD
Exemestane—Dizziness—Pregabalin—epilepsy syndrome	8.78e-05	0.000246	CcSEcCtD
Exemestane—Pain—Topiramate—epilepsy syndrome	8.76e-05	0.000245	CcSEcCtD
Exemestane—Constipation—Topiramate—epilepsy syndrome	8.76e-05	0.000245	CcSEcCtD
Exemestane—Asthenia—Gabapentin—epilepsy syndrome	8.74e-05	0.000244	CcSEcCtD
Exemestane—Nausea—Valproic Acid—epilepsy syndrome	8.72e-05	0.000244	CcSEcCtD
Exemestane—Pruritus—Gabapentin—epilepsy syndrome	8.61e-05	0.000241	CcSEcCtD
Exemestane—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	8.61e-05	0.00916	CbGpPWpGaD
Exemestane—Vomiting—Pregabalin—epilepsy syndrome	8.44e-05	0.000236	CcSEcCtD
Exemestane—Feeling abnormal—Topiramate—epilepsy syndrome	8.44e-05	0.000236	CcSEcCtD
Exemestane—Gastrointestinal pain—Topiramate—epilepsy syndrome	8.38e-05	0.000234	CcSEcCtD
Exemestane—Rash—Pregabalin—epilepsy syndrome	8.37e-05	0.000234	CcSEcCtD
Exemestane—Dermatitis—Pregabalin—epilepsy syndrome	8.36e-05	0.000234	CcSEcCtD
Exemestane—Diarrhoea—Gabapentin—epilepsy syndrome	8.33e-05	0.000233	CcSEcCtD
Exemestane—Headache—Pregabalin—epilepsy syndrome	8.32e-05	0.000233	CcSEcCtD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	8.27e-05	0.0088	CbGpPWpGaD
Exemestane—Urticaria—Topiramate—epilepsy syndrome	8.14e-05	0.000228	CcSEcCtD
Exemestane—Abdominal pain—Topiramate—epilepsy syndrome	8.1e-05	0.000227	CcSEcCtD
Exemestane—Body temperature increased—Topiramate—epilepsy syndrome	8.1e-05	0.000227	CcSEcCtD
Exemestane—Dizziness—Gabapentin—epilepsy syndrome	8.05e-05	0.000225	CcSEcCtD
Exemestane—Nausea—Pregabalin—epilepsy syndrome	7.89e-05	0.000221	CcSEcCtD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	7.88e-05	0.00838	CbGpPWpGaD
Exemestane—Vomiting—Gabapentin—epilepsy syndrome	7.74e-05	0.000217	CcSEcCtD
Exemestane—Rash—Gabapentin—epilepsy syndrome	7.68e-05	0.000215	CcSEcCtD
Exemestane—Dermatitis—Gabapentin—epilepsy syndrome	7.67e-05	0.000215	CcSEcCtD
Exemestane—Headache—Gabapentin—epilepsy syndrome	7.63e-05	0.000213	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—SRC—epilepsy syndrome	7.62e-05	0.00811	CbGpPWpGaD
Exemestane—Hypersensitivity—Topiramate—epilepsy syndrome	7.55e-05	0.000211	CcSEcCtD
Exemestane—Asthenia—Topiramate—epilepsy syndrome	7.35e-05	0.000206	CcSEcCtD
Exemestane—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	7.28e-05	0.00774	CbGpPWpGaD
Exemestane—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	7.26e-05	0.00773	CbGpPWpGaD
Exemestane—Pruritus—Topiramate—epilepsy syndrome	7.25e-05	0.000203	CcSEcCtD
Exemestane—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	7.24e-05	0.0077	CbGpPWpGaD
Exemestane—Nausea—Gabapentin—epilepsy syndrome	7.23e-05	0.000202	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	7.12e-05	0.00757	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	7.12e-05	0.00757	CbGpPWpGaD
Exemestane—Diarrhoea—Topiramate—epilepsy syndrome	7.01e-05	0.000196	CcSEcCtD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	6.85e-05	0.00729	CbGpPWpGaD
Exemestane—Testosterone—ALB—epilepsy syndrome	6.78e-05	0.00973	CrCbGaD
Exemestane—Dizziness—Topiramate—epilepsy syndrome	6.77e-05	0.00019	CcSEcCtD
Exemestane—Vomiting—Topiramate—epilepsy syndrome	6.51e-05	0.000182	CcSEcCtD
Exemestane—Testosterone—ABCB1—epilepsy syndrome	6.47e-05	0.00929	CrCbGaD
Exemestane—Rash—Topiramate—epilepsy syndrome	6.46e-05	0.000181	CcSEcCtD
Exemestane—Dermatitis—Topiramate—epilepsy syndrome	6.45e-05	0.000181	CcSEcCtD
Exemestane—Headache—Topiramate—epilepsy syndrome	6.42e-05	0.00018	CcSEcCtD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	6.24e-05	0.00664	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—CYP2C19—epilepsy syndrome	6.11e-05	0.00651	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TSC1—epilepsy syndrome	6.09e-05	0.00648	CbGpPWpGaD
Exemestane—Nausea—Topiramate—epilepsy syndrome	6.08e-05	0.00017	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—CYP11A1—epilepsy syndrome	6.08e-05	0.00647	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	6.03e-05	0.00642	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	5.99e-05	0.00638	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—CYP2D6—epilepsy syndrome	5.48e-05	0.00584	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	5.41e-05	0.00576	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	5.39e-05	0.00574	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	5.33e-05	0.00568	CbGpPWpGaD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	5.06e-05	0.00538	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.93e-05	0.00525	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.75e-05	0.00505	CbGpPWpGaD
Exemestane—CYP19A1—FSH signaling pathway—AKT1—epilepsy syndrome	4.74e-05	0.00504	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CDC42—epilepsy syndrome	4.63e-05	0.00493	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—epilepsy syndrome	4.4e-05	0.00468	CbGpPWpGaD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	4.39e-05	0.00467	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	4.31e-05	0.00459	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CA13—epilepsy syndrome	4.18e-05	0.00445	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	4.18e-05	0.00445	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	4.17e-05	0.00444	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	4.14e-05	0.00441	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	4.12e-05	0.00438	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	4.09e-05	0.00435	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	4.06e-05	0.00432	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	3.72e-05	0.00395	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	3.67e-05	0.0039	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	3.55e-05	0.00377	CbGpPWpGaD
Exemestane—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	3.37e-05	0.00359	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.37e-05	0.00358	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	3.36e-05	0.00357	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	3.34e-05	0.00356	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	3.34e-05	0.00355	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GLUD1—epilepsy syndrome	3.17e-05	0.00337	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CERS1—epilepsy syndrome	3.17e-05	0.00337	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—L2HGDH—epilepsy syndrome	3.17e-05	0.00337	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ADK—epilepsy syndrome	3.17e-05	0.00337	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PDXK—epilepsy syndrome	3.17e-05	0.00337	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—FAR1—epilepsy syndrome	3.17e-05	0.00337	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	3.01e-05	0.00321	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	2.92e-05	0.0031	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NHLRC1—epilepsy syndrome	2.9e-05	0.00308	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GAMT—epilepsy syndrome	2.9e-05	0.00308	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—EPM2A—epilepsy syndrome	2.9e-05	0.00308	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PNPO—epilepsy syndrome	2.9e-05	0.00308	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—QDPR—epilepsy syndrome	2.69e-05	0.00287	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CA4—epilepsy syndrome	2.69e-05	0.00287	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—POMC—epilepsy syndrome	2.69e-05	0.00286	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—COX3—epilepsy syndrome	2.53e-05	0.0027	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	2.5e-05	0.00266	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLCO1A2—epilepsy syndrome	2.4e-05	0.00256	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC6A8—epilepsy syndrome	2.4e-05	0.00256	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CACNA2D2—epilepsy syndrome	2.4e-05	0.00256	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—KCNB1—epilepsy syndrome	2.4e-05	0.00256	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PFKL—epilepsy syndrome	2.4e-05	0.00256	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	2.4e-05	0.00255	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.35e-05	0.0025	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.33e-05	0.00248	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	2.21e-05	0.00235	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ATIC—epilepsy syndrome	2.2e-05	0.00234	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—UPB1—epilepsy syndrome	2.2e-05	0.00234	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NEU1—epilepsy syndrome	2.2e-05	0.00234	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	2.14e-05	0.00228	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HSD17B4—epilepsy syndrome	2.11e-05	0.00225	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GBE1—epilepsy syndrome	2.04e-05	0.00217	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PPP1R3C—epilepsy syndrome	2.04e-05	0.00217	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2e-05	0.00212	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ASAH1—epilepsy syndrome	1.92e-05	0.00204	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	1.87e-05	0.00199	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—STXBP1—epilepsy syndrome	1.87e-05	0.00199	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.82e-05	0.00194	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NT5E—epilepsy syndrome	1.82e-05	0.00194	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALAD—epilepsy syndrome	1.82e-05	0.00194	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.78e-05	0.0019	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.77e-05	0.00189	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.76e-05	0.00187	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.75e-05	0.00186	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALDH7A1—epilepsy syndrome	1.74e-05	0.00185	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CACNA1A—epilepsy syndrome	1.74e-05	0.00185	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ST3GAL3—epilepsy syndrome	1.7e-05	0.00181	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ADSL—epilepsy syndrome	1.66e-05	0.00177	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GLUL—epilepsy syndrome	1.63e-05	0.00174	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CACNA1D—epilepsy syndrome	1.6e-05	0.00171	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.6e-05	0.0017	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.58e-05	0.00168	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TXNRD1—epilepsy syndrome	1.5e-05	0.0016	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.48e-05	0.00157	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AQP1—epilepsy syndrome	1.46e-05	0.00155	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.4e-05	0.00149	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—KCNJ11—epilepsy syndrome	1.32e-05	0.0014	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CHRM3—epilepsy syndrome	1.32e-05	0.0014	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.23e-05	0.0013	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.22e-05	0.0013	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.2e-05	0.00128	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	1.2e-05	0.00127	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCG2—epilepsy syndrome	1.07e-05	0.00114	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP2C19—epilepsy syndrome	1.05e-05	0.00111	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP11A1—epilepsy syndrome	1.04e-05	0.00111	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.03e-05	0.0011	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	9.41e-06	0.001	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP2D6—epilepsy syndrome	9.38e-06	0.000998	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	9.25e-06	0.000984	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	9.25e-06	0.000984	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CERS1—epilepsy syndrome	9.25e-06	0.000984	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PDXK—epilepsy syndrome	9.25e-06	0.000984	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—FAR1—epilepsy syndrome	9.25e-06	0.000984	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ADK—epilepsy syndrome	9.25e-06	0.000984	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ADRA2A—epilepsy syndrome	8.93e-06	0.00095	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—BCHE—epilepsy syndrome	8.89e-06	0.000946	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC2A1—epilepsy syndrome	8.48e-06	0.000902	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GAMT—epilepsy syndrome	8.46e-06	0.0009	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	8.46e-06	0.0009	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PNPO—epilepsy syndrome	8.46e-06	0.0009	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	8.46e-06	0.0009	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PLCB1—epilepsy syndrome	8.39e-06	0.000893	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TH—epilepsy syndrome	8.36e-06	0.000889	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.23e-06	0.000876	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.86e-06	0.000837	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.86e-06	0.000837	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.84e-06	0.000834	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—COX3—epilepsy syndrome	7.39e-06	0.000787	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	7.01e-06	0.000746	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	7.01e-06	0.000746	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PFKL—epilepsy syndrome	7.01e-06	0.000746	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	7.01e-06	0.000746	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	7.01e-06	0.000746	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HMOX1—epilepsy syndrome	6.98e-06	0.000742	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CAT—epilepsy syndrome	6.88e-06	0.000732	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCB1—epilepsy syndrome	6.7e-06	0.000713	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6.41e-06	0.000682	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6.41e-06	0.000682	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6.41e-06	0.000682	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GPX1—epilepsy syndrome	6.22e-06	0.000662	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.17e-06	0.000657	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.96e-06	0.000634	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.96e-06	0.000634	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.6e-06	0.000596	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AGT—epilepsy syndrome	5.46e-06	0.000581	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.45e-06	0.00058	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—APOE—epilepsy syndrome	5.35e-06	0.000569	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.31e-06	0.000565	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.31e-06	0.000565	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.07e-06	0.000539	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.07e-06	0.000539	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.96e-06	0.000528	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.86e-06	0.000517	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.76e-06	0.000507	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.68e-06	0.000498	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—POMC—epilepsy syndrome	4.59e-06	0.000489	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.37e-06	0.000466	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.25e-06	0.000452	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALB—epilepsy syndrome	4.19e-06	0.000446	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.84e-06	0.000409	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.84e-06	0.000409	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	3.66e-06	0.00039	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.13e-06	0.000333	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.05e-06	0.000325	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.03e-06	0.000323	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.74e-06	0.000291	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.61e-06	0.000277	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.59e-06	0.000276	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.47e-06	0.000263	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.45e-06	0.000261	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TH—epilepsy syndrome	2.44e-06	0.00026	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.04e-06	0.000217	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.01e-06	0.000214	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.95e-06	0.000208	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKT1—epilepsy syndrome	1.84e-06	0.000196	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.82e-06	0.000193	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.59e-06	0.00017	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.56e-06	0.000166	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.34e-06	0.000143	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.22e-06	0.00013	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.07e-06	0.000114	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.37e-07	5.72e-05	CbGpPWpGaD
